Related Experiment Videos

What is "heart rate variability" and is it blunted by tumor necrosis factor?

|March 12, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Cardiotropic AAV gene therapy for heart failure: a phase 1 trial.

Nature medicine·2025

Intracoronary Gene Transfer of Adenylyl Cyclase 6 in Patients With Heart Failure: A Randomized Clinical Trial.

JAMA cardiology·2016

β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.

Journal of molecular and cellular cardiology·2011

Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity (CHARM) programme.

European journal of heart failure·2010

Beta-adrenergic stimulation induces interleukin-18 expression via beta2-AR, PI3K, Akt, IKK, and NF-kappaB.

Biochemical and biophysical research communications·2004

Failure of benefit and early hazard of bucindolol for Class IV heart failure.

Journal of cardiac failure·2003

See all related articles